Search Results 221-230 of 16229 for Chronic Lymphocytic Leukemia

1. Publications - Pedro Horna, M.D. - Mayo Clinic

   Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Am J Clin Pathol. 2022 Feb 3; 157 (2): ...

2. Chronic Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

   ... acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML) blastic phase (BP) and if this disease will respond better to nilotinib combined ...

3. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia - Mayo Clinic

   A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · Share ...

4. Risk-Adapted Chemotherapy in Younger Patients with Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia - Mayo Clinic

   Clinical Trials · Risk-Adapted Chemotherapy in Younger Patients with Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia · More about research at Mayo ...

5. Leukemia - Diagnosis and treatment - Mayo Clinic

   Doctors may find chronic leukemia in a routine blood test, before symptoms begin. If this happens, or if you have signs or symptoms that suggest leukemia ...

6. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

   ... acute lymphoblastic leukemia (ALL). Dasatinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in ...

7. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

   Hematologist / Oncologist. Jacksonville, FL. Areas of focus: Chronic lymphocytic leukemia, Acute lymphocytic leukemia, Acute myelogenous leukemia, ...

8. Cancer Physicians - Medical Professionals - Mayo Clinic

   Talha Badar, M.B.B.S., M.D.. Jacksonville, FL. Area of Focus: Chronic lymphocytic leukemia, Acute lymphocytic leukemia, Acute myelogenous leukemia, ...

9. Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma - Mayo Clinic

   ... acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

10. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

    subjects with rrCLL are in survival follow-up. Must have a confirmed diagnosis of CLL defined by 2008 International Workshop on Chronic Lymphocytic Leukemia ( ...